Rho激酶抑制剂在慢性充血性心力衰竭治疗中的应用(2)
![]() |
第1页 |
参见附件。
[3]张曼,屈晨,曾定尹.Rho/Rho激酶在压力负荷心力衰竭大鼠心肌组织的表达[J].中华心血管病杂志,2005,33(1):73-76.
[4]孟祥军,齐杰,田莉.12盐酸法舒地尔的合成、药理和临床研究进展[J].沈阳医学院学报,2010,12(1):45-50.
[5]NakamuraK,NishimuraJ,HranoK,eta1.Hydroxyfasudil,anactivemetaboliteoffasudilhydrochloride,relaxestherabbitbasilararterybydisinhibitionofmyosinlightchainphosphatase[J].JCerebBloodFlowMetab,2001,21(7):876—885.
[6]WangYX,Martin—McNultyB,daCunbaV,etal.Fasudil,aRho-kinaseinhibitor,attenuatesangiotensinII-inducedabdominalaorticaneurysminapolipoproteinE-deficientmicebyinhibitingapoptosisandproteolysis[J].Circulation,2005,111:2219-2226.
[7]HattoriT,ShimokawaH,HigashiM.Long-terminhibitionofRho-kinasesuppressesleftventricularremodelingaftermyocardialinfarctioninmice[J].Circulation,2004,109:2234—2239.
[8]RikitakeY,KimYY,HuangZ,eta1.InhibitionofRhokinase(ROCK)1eadstoincreasedcerebralbloodflowandstrokeprotection[J].Stroke,2005,36:2251—2257.
[9]WolfrumS,DendorferA,RikitakeY,eta1.InhibitionofRho-kinaseleadstorapidactivationofphosphatidylinositol3-kinasa/proteinkinaseAktandcardiovascularprotection[J].ArteriosclerThrombVaseBiol,2004,24:1842—1847.
[10]WangYX,daCunhaV,Martin—McNultyB,eta1.InhibitionofRho-kinasebyfasudilattenuatedangiotensinII-inducedcardiachypertrophyinapolipoproteinEdeftcientmice[J].EurJPharmacol,2005,512(2—3):215—222.
[11]罗洁,闵苏.新型脑、心血管活性药—法舒地尔[J].中国新药与临床杂志,2006,25(12):941-945.
您现在查看是摘要介绍页,详见PDF附件(3263kb)。